Duncan Moore bought ASPI once, on Jun 29, 2023
Director at ASP Isotopes Inc.
SEC CIK 0001888265 · Filings on SEC.gov ↗
Duncan Moore's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
2 filings since Jul 2023, newest first
About Duncan Moore
Duncan Moore, Ph.D. is a healthcare industry investment professional and corporate director with over three decades of experience in financial markets and biotech equity research. He has served as a director of ASP Isotopes Inc. since October 2021( where he participates on the company's Audit and Governance committees( Moore is a partner at East West Capital Partners, a healthcare-focused investment firm in Asia, where he has worked since May 2008( Prior to this, he spent 17 years at Morgan Stanley from 1991 to 2008, where he was a top-ranked pharmaceutical analyst and led the firm's global healthcare equity research team( As of April 2026, Moore holds approximately 1.04 million shares of ASP Isotopes valued at over $5.4 million, representing significant ownership in the development-stage advanced materials company focused on isotope production and commercialization(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.